Longitudinal association of PCSK9 sequence variations with low-density lipoprotein cholesterol levels: the Coronary Artery Risk Development in Young Adults Study.
about
Mechanisms and genetic determinants regulating sterol absorption, circulating LDL levels, and sterol elimination: implications for classification and disease riskPCSK9 (Proprotein convertase subtilisin/kexin type 9) inhibitors: past, present, and the futureWhat is the impact of PCSK9 rs505151 and rs11591147 polymorphisms on serum lipids level and cardiovascular risk: a meta-analysisEffects of PCSK9 genetic variants on plasma LDL cholesterol levels and risk of premature myocardial infarction in the Italian populationLiving the PCSK9 adventure: from the identification of a new gene in familial hypercholesterolemia towards a potential new class of anticholesterol drugs.The proprotein convertase subtilisin/kexin type 9 gene E670G polymorphism and serum lipid levels in the Guangxi Bai Ku Yao and Han populationsBoth rare and common variants in PCSK9 influence plasma low-density lipoprotein cholesterol level in American IndiansGene expression variation between African Americans and whites is associated with coronary artery calcification: the multiethnic study of atherosclerosisPremature coronary artery disease and familial hypercholesterolemia: need for early diagnosis and cascade screening in the Indian population.An anti-PCSK9 antibody reduces LDL-cholesterol on top of a statin and suppresses hepatocyte SREBP-regulated genesThe Influence of OLR1 and PCSK9 Gene Polymorphisms on Ischemic Stroke: Evidence from a Meta-AnalysisThe associations between proprotein convertase subtilisin/kexin type 9 E670G polymorphism and the risk of coronary artery disease and serum lipid levels: a meta-analysis.Several genetic polymorphisms interact with overweight/obesity to influence serum lipid levels.Differential effects of PCSK9 loss of function variants on serum lipid and PCSK9 levels in Caucasian and African Canadian populations.Genome-wide characterization of shared and distinct genetic components that influence blood lipid levels in ethnically diverse human populationsPredictive genetic testing for coronary artery disease.The role of proprotein convertase subtilisin/kexin type 9 in hyperlipidemia: focus on therapeutic implications.Current Phase II proprotein convertase subtilisin/kexin 9 inhibitor therapies for dyslipidemia.Proprotein convertase subtilisin/kexin 9 inhibitors: an emerging lipid-lowering therapy?Lipid lowering with PCSK9 inhibitors.PCSK9 Loss-of-Function Variants, Low-Density Lipoprotein Cholesterol, and Risk of Coronary Heart Disease and Stroke: Data From 9 Studies of Blacks and Whites.Monoclonal Antibodies for Lipid Management.Effect of E670G Polymorphism in PCSK9 Gene on the Risk and Severity of Coronary Heart Disease and Ischemic Stroke in a Tunisian Cohort.Proprotein convertase subtilisin/kexin type 9 gene E670G polymorphism interacts with alcohol consumption to modulate serum lipid levels.Cardiovascular risk reduction in African Americans: Current concepts and controversies.Interactions of several single nucleotide polymorphisms and high body mass index on serum lipid traits.Short- and long-term effects of xuezhikang, an extract of cholestin, on serum proprotein convertase subtilisin/kexin type 9 levels.Ossabaw Pigs With a PCSK9 Gain-of-Function Mutation Develop Accelerated Coronary Atherosclerotic Lesions: A Novel Model for Preclinical Studies.
P2860
Q27003094-13597750-016D-49A2-8C4C-13362D0331B6Q28083595-08F32970-4F88-4058-B416-3ED1B1CAFBB8Q33792275-67BFA1A9-A8C0-4138-A148-C7638B5BE2ABQ34188099-A78F4CAD-F1FD-4854-89D8-AA5125AA0220Q34430377-2DF37285-4533-471A-B581-77F0FA41DF5CQ34559768-D8AA34A8-B6F5-451C-8953-813D44D88911Q35055010-4CB18807-3770-4B19-AE54-319AE5C5D3EDQ35095203-960ACE63-7EF1-4302-9222-DDA0F3B87864Q35494775-74642F08-059D-4627-A9EB-204B3198E83CQ35767551-9873C8F3-8D3E-4BD0-AF9E-07F378A9079FQ35868554-1A2F5A8E-B0A6-4ECC-BE0F-30548B55B545Q36292659-9339435F-FB45-40FA-9648-91C319B7EAA1Q36430298-FC6359CA-8A20-4823-AB62-6E667720AB5AQ36866980-64CEE382-BB8A-490B-AB1A-4E5E41134E2AQ36909249-5EC817C2-1A0D-4B88-91FF-45039344B045Q37643740-C8A748E0-3ACF-4D12-BF3B-E9188BB5BB8AQ37880856-94D225B3-8CB3-478A-A775-61EE3DA5A0B8Q38124404-D1D23E76-92DC-432E-8F83-25E5C515AAF2Q38221015-2AF1FF6B-7F95-4AF8-AFBC-979758F1AF60Q38222649-E216F195-5D4B-4678-BA8A-289861490135Q38646050-BBD03330-482F-4541-9AF9-9E555A9B4EF2Q38843479-5D0C18B5-1C99-419F-857F-BEB80EE0FC62Q39470591-EEA1610B-5EFC-427A-B282-E757567B167CQ42118645-00AF4A4F-7468-49FB-9DC9-9C541259E204Q42378575-1CE8A1D7-DC60-4F3B-9BA8-DCA6CDA7A874Q44162391-242F8FE8-C11D-4C54-A08A-AA2BA0BCDAFAQ44496513-BE3097F5-9B58-4ADC-98FE-5E3BCA052635Q51556455-5116D113-FA86-4561-B262-0CC3A193E120
P2860
Longitudinal association of PCSK9 sequence variations with low-density lipoprotein cholesterol levels: the Coronary Artery Risk Development in Young Adults Study.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Longitudinal association of PC ...... lopment in Young Adults Study.
@ast
Longitudinal association of PC ...... lopment in Young Adults Study.
@en
type
label
Longitudinal association of PC ...... lopment in Young Adults Study.
@ast
Longitudinal association of PC ...... lopment in Young Adults Study.
@en
prefLabel
Longitudinal association of PC ...... lopment in Young Adults Study.
@ast
Longitudinal association of PC ...... lopment in Young Adults Study.
@en
P2093
P2860
P50
P1476
Longitudinal association of PC ...... lopment in Young Adults Study.
@en
P2093
Chiang-Ching Huang
Gina S Wei
P2860
P304
P356
10.1161/CIRCGENETICS.108.828467
P577
2009-06-10T00:00:00Z